September 26, 2016 4:14 PM ET


Company Overview of Trimeris Inc

Company Overview

As of November 2, 2011, Trimeris Inc was acquired by Synageva BioPharma Corp., in a reverse merger transaction. Trimeris, Inc., a biopharmaceutical company, engages in the development of a class of antiviral drug treatments. Its fusion inhibitors prevent viral fusion, a complex process by which viruses attach to, penetrate, and infect host cells. The company offers FUZEON, a 36-amino acid synthetic peptide that binds to a key region of a human immunodeficiency virus (HIV) surface protein called gp41; and blocks HIV viral fusion by interfering with certain structural rearrangements within gp41 that are required for HIV to fuse to and enter a host cell. It has a development and license agreeme...

2530 Meridian Parkway

2nd Floor

Durham, NC 27713

United States

Founded in 1993

3 Employees





Key Executives for Trimeris Inc

Trimeris Inc does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Trimeris Inc, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at